Acuitas Investments, LLC Ikena Oncology, Inc. Transaction History

Acuitas Investments, LLC

  • $106 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$1.6 - $1.85 $79,643 - $92,087
49,777 Added 12.45%
449,656 $777,000
Q2 2024

Aug 05, 2024
BUY
$1.24 - $1.82 $2,644 - $3,882
2,133 Added 0.54%
399,879 $659,000
Q1 2024

May 10, 2024
BUY
$1.27 - $2.0 $505,137 - $795,492
397,746 New
397,746 $564,000

Others Institutions Holding IKNA

# of Institutions
55
Shares Held
31.9M
Call Options Held
0
Put Options Held
0
View Full List

About Ikena Oncology, Inc.

IKNA Quotes by TradingView
  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $46.8M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Acuitas Investments, LLC Portfolio

Follow Acuitas Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuitas Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email